Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11441189 | Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphology | Karl Garsha, Phillip C. Miller, Ray B. Nagle, Michael Otter, Gary Pestano +1 more | 2022-09-13 |
| 10190173 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2019-01-29 |
| 9951388 | Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis | Karl Garsha, Phillip C. Miller, Ray B. Nagle, Michael Otter, Gary Pestano +1 more | 2018-04-24 |
| 9745635 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2017-08-29 |
| 9678077 | ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer | Mark A. Rubin, Juan Miguel Mosquera, Kyung Park, Ya-Lin Chiu | 2017-06-13 |
| 9284609 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2016-03-15 |
| 8969527 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2015-03-03 |
| 8580509 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2013-11-12 |
| 8211645 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2012-07-03 |
| 7981609 | Methods for identifying and using SNP panels | Mark A. Rubin, Levi A. Garraway, William R. Sellers | 2011-07-19 |
| 7803552 | Biomarkers for predicting prostate cancer progression | Mark A. Rubin | 2010-09-28 |
| 7718369 | Recurrent gene fusions in prostate cancer | Scott Tomlins, Daniel Rhodes, Arul M. Chinnaiyan, Rohit Mehra, Mark A. Rubin +3 more | 2010-05-18 |
| 7666595 | Biomarkers for predicting prostate cancer progression | Mark A. Rubin | 2010-02-23 |